WallStSmart

Crowdstrike Holdings Inc (CRWD)vsIDEXX Laboratories Inc (IDXX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Crowdstrike Holdings Inc generates 8% more annual revenue ($4.81B vs $4.45B). IDXX leads profitability with a 24.6% profit margin vs -3.4%. IDXX appears more attractively valued with a PEG of 3.53. IDXX earns a higher WallStSmart Score of 63/100 (C+).

CRWD

Hold

40

out of 100

Grade: D

Growth: 9.3Profit: 2.5Value: 3.0Quality: 6.0
Piotroski: 2/9Altman Z: 1.00

IDXX

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 9.5Value: 2.7Quality: 7.0
Piotroski: 6/9Altman Z: 5.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRWDSignificantly Overvalued (-79.7%)

Margin of Safety

-79.7%

Fair Value

$373.43

Current Price

$671.02

$297.59 premium

UndervaluedFair: $373.43Overvalued
IDXXSignificantly Overvalued (-53.2%)

Margin of Safety

-53.2%

Fair Value

$423.53

Current Price

$562.16

$138.63 premium

UndervaluedFair: $423.53Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRWD4 strengths · Avg: 9.0/10
EPS GrowthGrowth
533.0%10/10

Earnings expanding 533.0% YoY

Market CapQuality
$195.73B9/10

Large-cap with strong market position

Debt/EquityHealth
0.189/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
23.3%8/10

Revenue surging 23.3% year-over-year

IDXX4 strengths · Avg: 9.8/10
Return on EquityProfitability
70.4%10/10

Every $100 of equity generates 70 in profit

Operating MarginProfitability
31.8%10/10

Strong operational efficiency at 31.8%

Altman Z-ScoreHealth
5.9210/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
24.6%9/10

Keeps 25 of every $100 in revenue as profit

Areas to Watch

CRWD4 concerns · Avg: 2.5/10
Operating MarginProfitability
1.0%3/10

Operating margin of 1.0%

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
6.452/10

Expensive relative to growth rate

Price/BookValuation
38.4x2/10

Trading at 38.4x book value

IDXX3 concerns · Avg: 2.0/10
PEG RatioValuation
3.532/10

Expensive relative to growth rate

P/E RatioValuation
40.5x2/10

Premium valuation, high expectations priced in

Price/BookValuation
27.9x2/10

Trading at 27.9x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : CRWD

The strongest argument for CRWD centers on EPS Growth, Market Cap, Debt/Equity. Revenue growth of 23.3% demonstrates continued momentum.

Bull Case : IDXX

The strongest argument for IDXX centers on Return on Equity, Operating Margin, Altman Z-Score. Profitability is solid with margins at 24.6% and operating margin at 31.8%. Revenue growth of 14.3% demonstrates continued momentum.

Bear Case : CRWD

The primary concerns for CRWD are Operating Margin, Piotroski F-Score, PEG Ratio.

Bear Case : IDXX

The primary concerns for IDXX are PEG Ratio, P/E Ratio, Price/Book. A P/E of 40.5x leaves little room for execution misses.

Key Dynamics to Monitor

CRWD profiles as a growth stock while IDXX is a mature play — different risk/reward profiles.

IDXX carries more volatility with a beta of 1.57 — expect wider price swings.

CRWD is growing revenue faster at 23.3% — sustainability is the question.

CRWD generates stronger free cash flow (493M), providing more financial flexibility.

Bottom Line

IDXX scores higher overall (63/100 vs 40/100), backed by strong 24.6% margins and 14.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crowdstrike Holdings Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

CrowdStrike Holdings, Inc. provides cloud solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. The company is headquartered in Sunnyvale, California.

Visit Website →

IDEXX Laboratories Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.

Want to dig deeper into these stocks?